Evidence map›Paper›PMID 42635391›Full record

ArticleEuropean journal of immunology2026

The Glucose Transporter GLUT3 Controls Regulatory T Cell Function.

Katrin Sinning, Miriam Eckstein, Xiufeng Zhao, Alexandra Freitag, Mathias Rosenfeldt, Sophia M Hochrein, Martin Vaeth

Abstract read
In one paragraph

Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katrin SinningWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.ORCID 0009-0004-5841-2398
Miriam EcksteinWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.
Xiufeng ZhaoWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.
Alexandra FreitagWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.ORCID 0009-0000-5253-1784
Mathias RosenfeldtInstitute of Pathology, Julius-Maximilians-University of Würzburg, Würzburg, Germany.
Sophia M HochreinWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.ORCID 0000-0001-7864-4170
Martin VaethWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-University of Würzburg, Würzburg, Germany.ORCID 0000-0001-8974-7052

Funding

Deutsche Forschungsgemeinschaft
6 · The paper itself

Abstract

Regulatory T (Treg) cells are central mediators of immune tolerance and are generally considered to rely predominantly on mitochondrial metabolism rather than glucose-driven glycolysis. To define the role of glucose metabolism in Treg cells, we investigated the contribution of the hexose transporters GLUT1 and GLUT3. Genetic ablation of GLUT1 in T cells or selectively in Treg cells had minimal impact on Treg cell numbers, phenotype, or immune homeostasis, indicating that GLUT1 is largely dispensable in this lineage. By contrast, deletion of GLUT3 in T cells resulted in a marked reduction in Treg cell numbers. However, it remained unclear whether this reduction reflected diminished IL-2 production by GLUT3-deficient conventional T cells or a cell-intrinsic requirement for GLUT3 in Treg cells. To investigate this, we generated mice with Treg cell-specific deletion of GLUT3. These animals developed severe systemic inflammation accompanied by lethal cellular and humoral autoimmunity. Mechanistically, GLUT3-deficient Treg cells exhibited reduced glycolytic activity and mitochondrial respiration, leading to impaired suppressive function and defective effector and follicular Treg cell differentiation. Collectively, our findings demonstrate a nonredundant requirement for GLUT3 in Treg cell metabolic fitness and immune regulation, refining the prevailing view that Treg cells operate largely independently of glucose metabolism. Our data further suggest that therapeutic strategies targeting glucose uptake and glycolysis in autoimmune and inflammatory diseases should account for potential adverse effects on Treg cell-mediated immune tolerance.

Indexed as

Glucose Transporter Type 3T-Lymphocytes, RegulatoryAnimalsAutoimmunityCell DifferentiationGlucoseGlucose Transporter Type 1GlycolysisImmune ToleranceMiceMice, Inbred C57BLMice, KnockoutMitochondriaGlucoseGlucose Transporter Type 1Glucose Transporter Type 3Slc2a1 protein, mouseSlc2a3 protein, mousebiologycell biologycellular differentiationglucose transporterglucose uptakeglycolysisimmune toleranceimmunologyregulatory T cell

Identifiers

PMID42635391
PMCPMC13501943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.